VKTXViking Therapeutics, Inc.

Nasdaq vikingtherapeutics.com


$ 75.77 $ -0.67 (-0.88 %)    

Thursday, 02-May-2024 15:59:59 EDT
QQQ $ 429.07 $ 3.83 (0.9 %)
DIA $ 382.31 $ 3.34 (0.88 %)
SPY $ 505.01 $ 0.61 (0.12 %)
TLT $ 88.87 $ 0.31 (0.35 %)
GLD $ 213.12 $ -0.66 (-0.31 %)
$ 75.76
$ 78.00
$ 0.00 x 0
$ 0.00 x 0
$ 73.53 - $ 78.00
$ 8.28 - $ 99.41
2,048,519
na
7.84B
$ 1.29
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 04-25-2024 03-31-2024 10-Q
2 02-07-2024 12-31-2023 10-K
3 10-25-2023 09-30-2023 10-Q
4 07-26-2023 06-30-2023 10-Q
5 04-26-2023 03-31-2023 10-Q
6 02-10-2023 12-31-2022 10-K
7 10-26-2022 09-30-2022 10-Q
8 07-27-2022 06-30-2022 10-Q
9 04-27-2022 03-31-2022 10-Q
10 02-09-2022 12-31-2021 10-K
11 11-03-2021 09-30-2021 10-Q
12 07-28-2021 06-30-2021 10-Q
13 04-28-2021 03-31-2021 10-Q
14 02-17-2021 12-31-2020 10-K
15 10-28-2020 09-30-2020 10-Q
16 07-29-2020 06-30-2020 10-Q
17 04-30-2020 03-31-2020 10-Q
18 02-26-2020 12-31-2019 10-K
19 11-05-2019 09-30-2019 10-Q
20 08-01-2019 06-30-2019 10-Q
21 05-02-2019 03-31-2019 10-Q
22 03-13-2019 12-31-2018 10-K
23 11-07-2018 09-30-2018 10-Q
24 08-09-2018 06-30-2018 10-Q
25 05-09-2018 03-31-2018 10-Q
26 03-07-2018 12-31-2017 10-K
27 11-08-2017 09-30-2017 10-Q
28 08-09-2017 06-30-2017 10-Q
29 05-10-2017 03-31-2017 10-Q
30 03-21-2017 12-31-2016 10-K
31 11-10-2016 09-30-2016 10-Q
32 08-11-2016 06-30-2016 10-Q
33 05-10-2016 03-31-2016 10-Q
34 03-08-2016 12-31-2015 10-K
35 11-05-2015 09-30-2015 10-Q
36 08-14-2015 06-30-2015 10-Q
37 06-12-2015 03-31-2015 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 hc-wainwright--co-reiterates-buy-on-viking-therapeutics-maintains-90-price-target

HC Wainwright & Co. analyst Joseph Pantginis reiterates Viking Therapeutics (NASDAQ:VKTX) with a Buy and maintains $90 p...

 viking-therapeutics-reports-q1-results-an-exceptional-period-says-ceo

Viking Therapeutics reports quarterly losses of 26 cents per share which beat the analyst consensus estimate of losses of 28 ce...

 viking-therapeutics-q1-eps-026-beats-028-estimate

Viking Therapeutics (NASDAQ:VKTX) reported quarterly losses of $(0.26) per share which beat the analyst consensus estimate of $...

 oppenheimer-maintains-outperform-on-viking-therapeutics-raises-price-target-to-138

Oppenheimer analyst Jay Olson maintains Viking Therapeutics (NASDAQ:VKTX) with a Outperform and raises the price target from...

 oppenheimer-maintains-outperform-on-viking-therapeutics-raises-price-target-to-138

Oppenheimer analyst Jay Olson maintains Viking Therapeutics (NASDAQ:VKTX) with a Outperform and raises the price target from...

 stocks-inch-higher-tesla-rebounds-bitcoin-holds-below-70000-whats-driving-markets-tuesday

Wall Street is set to break a two-day losing streak on Tuesday, as major indices trended positively during midday trading in Ne...

 why-westport-fuel-systems-shares-are-trading-lower-by-around-10-here-are-other-stocks-moving-in-tuesdays-mid-day-session

Shares of Westport Fuel Systems Inc. (NASDAQ: WPRT) fell sharply during Tuesday’s session after posting a wider-than-expected ...

 btig-maintains-buy-on-viking-therapeutics-raises-price-target-to-125

BTIG analyst Justin Zelin maintains Viking Therapeutics (NASDAQ:VKTX) with a Buy and raises the price target from $100 to $125.

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION